Announcements Trials

Browse Landscape

Sponsor

Conditions

Prostatic Neoplasms 3 Toxemia 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Neoplasms 1 Myocarditis 1 Muscle Weakness 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Diabetes, Gestational 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Biopsy 4 Nivolumab 3 sodium-iodide symporter 2 fludarabine 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Photons 2 Mycophenolic Acid 2 Immunoglobulin G 2 Disulfides 2 Cyclosporine 2 treosulfan 1 talimogene laherparepvec 1 ruxolitinib 1 pembrolizumab 1 fludarabine phosphate 1 entrectinib 1 duvelisib 1 alectinib 1 Vinblastine 1 Tacrolimus 1 Standard of Care 1 Sirolimus 1 Practice Guidelines as Topic 1 Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × Positron-Emission Tomography × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡